• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Evaluation of the role and usefulness of clinical pharmacists at the Fangcang Hospital during COVID-19 outbreak.新型冠状病毒肺炎疫情期间临床药师在方舱医院的作用及价值评估
Int J Clin Pract. 2021 Aug;75(8):e14271. doi: 10.1111/ijcp.14271. Epub 2021 May 13.
2
Pharmacy administration and pharmaceutical care practice in a module hospital during the COVID-19 epidemic.在 COVID-19 疫情期间模块医院中的药学管理和药学服务实践。
J Am Pharm Assoc (2003). 2020 May-Jun;60(3):431-438.e1. doi: 10.1016/j.japh.2020.04.006. Epub 2020 Apr 10.
3
[Medication reconciliation on admission: One year of practice in health care institutions during the COVID-19 pandemic].入院时的用药重整:新冠疫情期间医疗机构一年的实践
Ann Pharm Fr. 2023 Sep;81(5):863-874. doi: 10.1016/j.pharma.2023.01.004. Epub 2023 Jan 31.
4
Impact of collaborative pharmaceutical care on in-patients' medication safety: study protocol for a stepped wedge cluster randomized trial (MEDREV study).协作药学服务对住院患者用药安全的影响:一项阶梯楔形整群随机试验的研究方案(MEDREV研究)
Trials. 2018 Jan 8;19(1):19. doi: 10.1186/s13063-017-2412-7.
5
The impact of pharmacist-led medication reconciliation and interprofessional ward rounds on drug-related problems at hospital discharge.药剂师主导的用药核对和跨专业病房查房对出院时药物相关问题的影响。
Int J Clin Pharm. 2023 Feb;45(1):117-125. doi: 10.1007/s11096-022-01496-3. Epub 2022 Nov 3.
6
Provision of clinical pharmacy services during the COVID-19 pandemic: Experiences of pharmacists from 16 European countries.新冠疫情期间临床药学服务的提供:来自16个欧洲国家药剂师的经验
Res Social Adm Pharm. 2021 Aug;17(8):1507-1517. doi: 10.1016/j.sapharm.2020.11.017. Epub 2020 Nov 30.
7
Impact of medication reconciliation and review and counselling, on adverse drug events and healthcare resource use.药物重整、审查与咨询对药物不良事件及医疗资源利用的影响。
Int J Clin Pharm. 2018 Oct;40(5):1154-1164. doi: 10.1007/s11096-018-0650-8. Epub 2018 May 12.
8
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
9
Management of COVID-19 patients in Fangcang shelter hospital: clinical practice and effectiveness analysis.方仓医院 COVID-19 患者管理:临床实践与效果分析。
Clin Respir J. 2021 Mar;15(3):280-286. doi: 10.1111/crj.13293. Epub 2020 Oct 28.
10
Implementation and evaluation of a collaborative clinical pharmacist's medications reconciliation and charting service for admitted medical inpatients in a metropolitan hospital.为一家大都市医院的住院内科患者实施并评估临床药师协作的用药核对与医嘱录入服务。
J Clin Pharm Ther. 2016 Dec;41(6):662-666. doi: 10.1111/jcpt.12442. Epub 2016 Aug 31.

引用本文的文献

1
Bibliometric and visual analysis of medication therapy management from 2003 to 2023.2003年至2023年药物治疗管理的文献计量学与可视化分析
Medicine (Baltimore). 2024 Dec 20;103(51):e40953. doi: 10.1097/MD.0000000000040953.
2
Telepharmacy Implementation to Support Pharmaceutical Care Services during the COVID-19 Pandemic: A Scoping Review.新冠疫情期间支持药学服务的远程药学实践:一项范围综述
Can J Hosp Pharm. 2024 Jan 10;77(1):e3430. doi: 10.4212/cjhp.3430. eCollection 2024.
3
Telepharmacy during home isolation: drug-related problems and pharmaceutical care in COVID-19 patients receiving antiviral therapy in Thailand.居家隔离期间的远程药学服务:泰国接受抗病毒治疗的COVID-19患者的药物相关问题及药学照护
J Pharm Policy Pract. 2023 Feb 24;16(1):29. doi: 10.1186/s40545-023-00538-z.
4
Adaptations in the role of pharmacists under the conditions of the COVID-19 pandemic: a systematic review and meta-analysis.COVID-19 大流行背景下药师角色的转变:系统评价和荟萃分析。
BMC Health Serv Res. 2023 Jan 24;23(1):72. doi: 10.1186/s12913-023-09071-w.
5
Systematic literature review of adopting eHealth in pharmaceutical care during COVID-19 pandemic: recommendations for strengthening pharmacy services.系统文献回顾在 COVID-19 大流行期间采用电子医疗在药物治疗中的应用:加强药学服务的建议。
BMJ Open. 2022 Nov 23;12(11):e066246. doi: 10.1136/bmjopen-2022-066246.
6
The Pharmacist's Role in Managing COVID-19 in Chronic Kidney Disease Patients: A Review of Existing Strategies and Future Implications.药剂师在慢性肾脏病患者新冠病毒病管理中的作用:现有策略及未来影响综述
Pharmacy (Basel). 2022 Aug 5;10(4):94. doi: 10.3390/pharmacy10040094.
7
Medication Adherence and Belief about Medication among Vietnamese Patients with Chronic Cardiovascular Diseases within the Context of Implementing Measures to Prevent COVID-19.在实施预防新冠疫情措施背景下越南慢性心血管疾病患者的药物依从性及对药物的认知
J Cardiovasc Dev Dis. 2022 Jun 26;9(7):202. doi: 10.3390/jcdd9070202.
8
Hyperlipidemia, COVID-19 and acute pancreatitis: A tale of three entities.高脂血症、COVID-19 和急性胰腺炎:三者之间的故事。
Am J Med Sci. 2022 Sep;364(3):257-263. doi: 10.1016/j.amjms.2022.03.007. Epub 2022 Apr 4.
9
Drug Interactions for Patients with Respiratory Diseases Receiving COVID-19 Emerged Treatments.接受新冠病毒治疗的呼吸疾病患者的药物相互作用。
Int J Environ Res Public Health. 2021 Nov 8;18(21):11711. doi: 10.3390/ijerph182111711.

本文引用的文献

1
COVID-19, a worldwide public health emergency.COVID-19,一场全球性的公共卫生紧急事件。
Rev Clin Esp (Barc). 2021 Jan;221(1):55-61. doi: 10.1016/j.rceng.2020.03.001. Epub 2020 Apr 21.
2
Roles of Clinical Pharmacists in Caring for Patients With Inflammatory Bowel Disease During COVID-19.新冠疫情期间临床药师在炎症性肠病患者护理中的作用
Gastroenterology. 2021 Apr;160(5):1880. doi: 10.1053/j.gastro.2020.05.044. Epub 2020 May 18.
3
Fangcang shelter hospitals: a novel concept for responding to public health emergencies.方仓庇护医院:应对突发公共卫生事件的新理念。
Lancet. 2020 Apr 18;395(10232):1305-1314. doi: 10.1016/S0140-6736(20)30744-3. Epub 2020 Apr 2.
4
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.洛匹那韦-利托那韦治疗成人重症 COVID-19 患者的临床试验。
N Engl J Med. 2020 May 7;382(19):1787-1799. doi: 10.1056/NEJMoa2001282. Epub 2020 Mar 18.
5
Therapeutic options for the 2019 novel coronavirus (2019-nCoV).2019新型冠状病毒(2019-nCoV)的治疗选择。
Nat Rev Drug Discov. 2020 Mar;19(3):149-150. doi: 10.1038/d41573-020-00016-0.
6
Therapeutic and triage strategies for 2019 novel coronavirus disease in fever clinics.发热门诊中2019新型冠状病毒病的治疗与分诊策略
Lancet Respir Med. 2020 Mar;8(3):e11-e12. doi: 10.1016/S2213-2600(20)30071-0. Epub 2020 Feb 13.
7
Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province.湖北省三级医院新型冠状病毒病例的临床特征。
Chin Med J (Engl). 2020 May 5;133(9):1025-1031. doi: 10.1097/CM9.0000000000000744.
8
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
9
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.中国武汉 99 例 2019 年新型冠状病毒肺炎患者的流行病学和临床特征:描述性研究。
Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.
10
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.

新型冠状病毒肺炎疫情期间临床药师在方舱医院的作用及价值评估

Evaluation of the role and usefulness of clinical pharmacists at the Fangcang Hospital during COVID-19 outbreak.

作者信息

Wang Dongyuan, Liu Yihui, Zeng Fang, Shi Chen, Cheng Fang, Han Yong, Zhang Yu

机构信息

Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Hubei Province Clinical Research Center for Precision Medicine for Critical Illness, Wuhan, China.

出版信息

Int J Clin Pract. 2021 Aug;75(8):e14271. doi: 10.1111/ijcp.14271. Epub 2021 May 13.

DOI:10.1111/ijcp.14271
PMID:33894041
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8250255/
Abstract

BACKGROUND

Fangcang Hospitals (cabin hospitals) played a key role in isolation and control of the infection sources during COVID-19 epidemic. Many patients at Fangcang Hospitals had complications or mental stress. As the doctors, nurses and paramedics presented in the emergency, there was a growing demand for clinical pharmacists to provide pharmaceutical care for the affected patients with chronic diseases via telemedicine.

OBJECTIVE

This study was a retrospective study to evaluate the usefulness of clinical prevention and control measures of clinical pharmacists at Jianghan Fangcang Hospital. Besides, this study proposed innovative strategies for developing pharmacy services to ensure the medication compliance, accuracy and cure rates under the epidemic.

METHODS

A total of 374 patients filled in the questionnaires and 349 patients were enrolled in this study. Patients who refused to receive pharmaceutical care were not included in this study. The pharmaceutical care included medication education via broadcast station, medication reconciliation, optimisation of drug use, monitor of adverse drug events and psychological comfort via WeChat one-to-one service. The data were collected from patients' interviews and the questionnaires of inpatients and discharged patients.

RESULTS

In Jianghan Fangcang Hospital, many patients had complications with hypertension (12.9%), hyperlipidaemia (9.2%), thyroid disease (8.9%), diabetes (7.2%), heart disease (3.4%), nephropathy (1.7%), cancer (1.1%) and other diseases (12.6%). After 35 days' pharmacy service, about 200 different questions had been solved by our clinical pharmacists, including drug usage (65.38%), medication reconciliation (55.13%), drug precautions (23.1%), adverse drug reactions (35.9%) and psychological counselling (32.05%). Most patients were satisfied with clinical pharmacist service (66.7% great, 18.0% good).

CONCLUSION

The results of the retrospective study indicated that clinical pharmacist can effectively reduce and prevent drug-related, life-related and COVID-19-related problems for COVID-19 patients, which is important for the disease recovery. This study also demonstrated that clinical pharmacist played a key role for patients' healthcare during the pandemic.

摘要

背景

方舱医院在新型冠状病毒肺炎疫情期间的传染源隔离与控制中发挥了关键作用。许多方舱医院的患者出现了并发症或精神压力。随着医生、护士和医护人员奔赴紧急情况现场,临床药师通过远程医疗为受影响的慢性病患者提供药学服务的需求日益增长。

目的

本研究是一项回顾性研究,旨在评估江汉方舱医院临床药师的临床防控措施的有效性。此外,本研究提出了在疫情期间发展药学服务的创新策略,以确保用药依从性、准确性和治愈率。

方法

共有374名患者填写了问卷,349名患者纳入本研究。拒绝接受药学服务的患者未纳入本研究。药学服务包括通过广播电台进行用药教育、用药核对、优化药物使用、监测药物不良事件以及通过微信一对一服务提供心理安慰。数据收集自患者访谈以及住院患者和出院患者的问卷。

结果

在江汉方舱医院,许多患者患有并发症,包括高血压(12.9%)、高脂血症(9.2%)、甲状腺疾病(8.9%)、糖尿病(7.2%)、心脏病(3.4%)、肾病(1.7%)、癌症(1.1%)和其他疾病(12.6%)。经过35天的药学服务,我们的临床药师解决了约200个不同的问题,包括药物使用(65.38%)、用药核对(55.13%)、药物注意事项(23.1%)、药物不良反应(35.9%)和心理咨询(32.05%)。大多数患者对临床药师服务满意(66.7%非常满意,18.0%满意)。

结论

回顾性研究结果表明,临床药师可以有效减少和预防新型冠状病毒肺炎患者的药物相关、生活相关和新型冠状病毒肺炎相关问题,这对疾病康复很重要。本研究还表明,临床药师在疫情期间对患者的医疗保健发挥了关键作用。